Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,488,029
  • Shares Outstanding, K 45,436
  • Annual Sales, $ 1,185 M
  • Annual Income, $ 2,050 K
  • EBIT $ 5 M
  • EBITDA $ 94 M
  • 60-Month Beta 0.79
  • Price/Sales 1.35
  • Price/Cash Flow 12.73
  • Price/Book 1.28

Options Overview Details

View History
  • Implied Volatility 69.11% (-14.43%)
  • Historical Volatility 43.92%
  • IV Percentile 83%
  • IV Rank 61.19%
  • IV High 89.58% on 04/08/25
  • IV Low 36.84% on 09/02/25
  • Expected Move (DTE 17) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.34
  • Today's Volume 47
  • Volume Avg (30-Day) 13
  • Put/Call OI Ratio 0.91
  • Today's Open Interest 938
  • Open Int (30-Day) 975
  • Expected Range 32.35 to 32.35

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.13
  • Number of Estimates 3
  • High Estimate 0.16
  • Low Estimate 0.10
  • Prior Year 0.08
  • Growth Rate Est. (year over year) +62.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.19 +0.51%
on 03/20/26
42.43 -23.76%
on 03/05/26
-8.75 (-21.29%)
since 02/27/26
3-Month
32.19 +0.51%
on 03/20/26
55.00 -41.18%
on 01/13/26
-14.05 (-30.28%)
since 12/26/25
52-Week
22.66 +42.76%
on 05/06/25
55.00 -41.18%
on 01/13/26
-2.66 (-7.60%)
since 03/28/25

Most Recent Stories

More News
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

OMCL : 32.35 (-1.22%)
PODD : 208.01 (-0.10%)
ALGN : 166.26 (-0.07%)
DXCM : 61.90 (-0.56%)
QDEL : 15.26 (+3.25%)
3 Cash-Heavy Stocks with Warning Signs

3 Cash-Heavy Stocks with Warning Signs

OMCL : 32.35 (-1.22%)
DV : 9.49 (+1.93%)
PUBM : 8.12 (-0.85%)
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

OMCL : 32.35 (-1.22%)
3 Cash-Producing Stocks We Find Risky

3 Cash-Producing Stocks We Find Risky

MGM : 35.62 (-1.93%)
HOLX : 75.55 (-0.16%)
OMCL : 32.35 (-1.22%)
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

GH : 86.20 (+1.88%)
OMCL : 32.35 (-1.22%)
PACB : 1.2600 (unch)
ALGN : 166.26 (-0.07%)
QDEL : 15.26 (+3.25%)
The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call

The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call

OMCL : 32.35 (-1.22%)
OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook

OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook

OMCL : 32.35 (-1.22%)
Why Omnicell (OMCL) Shares Are Plunging Today

Why Omnicell (OMCL) Shares Are Plunging Today

OMCL : 32.35 (-1.22%)
Omnicell: Q4 Earnings Snapshot

Omnicell: Q4 Earnings Snapshot

OMCL : 32.35 (-1.22%)
Omnicell’s (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

Omnicell’s (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

OMCL : 32.35 (-1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution,...

See More

Key Turning Points

3rd Resistance Point 34.28
2nd Resistance Point 33.88
1st Resistance Point 33.11
Last Price 32.35
1st Support Level 31.94
2nd Support Level 31.54
3rd Support Level 30.77

See More

52-Week High 55.00
Fibonacci 61.8% 42.65
Fibonacci 50% 38.83
Fibonacci 38.2% 35.01
Last Price 32.35
52-Week Low 22.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.